Lanlan Li
Impact in
- Cell Biology top 10%
- Hippo pathway signaling and YAP/TAZ
-
- Cancer-related molecular mechanisms research
Papers in
-
- Epigenetics and DNA Methylation 5
- Mitochondrial Function and Pathology 5
- Ubiquitin and proteasome pathways 3
- ATP Synthase and ATPases Research 3
- RNA regulation and disease 3
- Advanced biosensing and bioanalysis techniques 3
-
- Cancer-related molecular mechanisms research 6
- Co-authors
- Hui Jiang (4 shared papers)Huanxiang Liu (9 shared papers)Xiaojun Yao (8 shared papers)Xi Wu (2 shared papers)Yuzhen Niu (2 shared papers)Yan Zhang (4 shared papers)Qianqian Wang (2 shared papers)Jing Zheng (2 shared papers)
- Journals
- BMC Genomics (3 papers)Frontiers in Pharmacology (2 papers)Food Chemistry (2 papers)Microchemical Journal (2 papers)Acta Pharmaceutica Sinica B (1 paper)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Lanlan Li
67 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 136
- Cell Biology 164
- Cancer Research 128
- Molecular Biology 562
- Biochemistry 44
- Health, Toxicology and Mutagenesis 81
Countries citing papers authored by Lanlan Li
This map shows the geographic impact of Lanlan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanlan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanlan Li more than expected).
Fields of papers citing papers by Lanlan Li
This network shows the impact of papers produced by Lanlan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanlan Li. The network helps show where Lanlan Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Lanlan Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 122 | |
| 2 | 2015 | 102 | |
| 3 | 2021 | 94 | |
| 4 | 2014 | 55 | |
| 5 | 2019 | 46 | |
| 6 | 2013 | 39 | |
| 7 | 2017 | 36 | |
| 8 | 2021 | 35 | |
| 9 | 2017 | 34 | |
| 10 | 2015 | 34 | |
| 11 | 2016 | 33 | |
| 12 | 2018 | 32 | |
| 13 | 2022 | 32 | |
| 14 | 2020 | 30 | |
| 15 | 2020 | 27 | |
| 16 | 2017 | 25 | |
| 17 | 2018 | 23 | |
| 18 | 2021 | 22 | |
| 19 | 2023 | 22 | |
| 20 | Protective and sensitive effects of melatonin combined with adriamycin on ER+ (estrogen receptor) breast cancer. | 2015 | 20 |
About Lanlan Li
Lanlan Li is a scholar working on Molecular Biology, Cancer Research, Genetics, Oncology and Cell Biology, having authored 73 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), Epigenetics and DNA Methylation (5 papers), Mitochondrial Function and Pathology (5 papers), Ubiquitin and proteasome pathways (3 papers), ATP Synthase and ATPases Research (3 papers), Adipose Tissue and Metabolism (3 papers), RNA regulation and disease (3 papers) and Advanced biosensing and bioanalysis techniques (3 papers). The work is most often cited by research in Cell Biology (164 citations), Cancer Research (128 citations), Molecular Biology (562 citations), Biochemistry (44 citations) and Health, Toxicology and Mutagenesis (81 citations). Lanlan Li has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Hui Jiang, Huanxiang Liu, Xiaojun Yao, Xi Wu, Yuzhen Niu, Yan Zhang, Qianqian Wang, Jing Zheng, Yongxia Qiao and Weifan Xiao. Their work appears in journals such as BMC Genomics, Frontiers in Pharmacology, Food Chemistry, Microchemical Journal and Acta Pharmaceutica Sinica B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.